David Morris

Rucaparib or Physician’s Choice in Metastatic Prostate Cancer

Karim Fizazi, Josep M. Piulats, M. Neil Reaume et al. · New England Journal of Medicine · 2023 · 380 citations · Full text

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

James W.F. Catto, Ben Tran, Morgan Rouprêt et al. · Annals of Oncology · 2023 · 67 citations · Full text

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

Christopher J. Sweeney, Ivor Percent, Sunil Babu et al. · Clinical Cancer Research · 2022 · 42 citations · Full text

Practice Based Collaboration to Improve the Use of Immediate Intravesical Therapy after Resection of Nonmuscle Invasive Bladder Cancer

Daniel A. Barocas, Alice Liu, Frank Burks et al. · The Journal of Urology · 2013 · 38 citations

Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

Mark D. Tyson, David Morris, Juan Palou et al. · The Journal of Urology · 2023 · 35 citations · Full text